The U.S. pharma giant posted profits of $775 million, or 13¢ per share, for the 3 months ended December 31, 2016, compared to a bottom-line loss of $172 million in the same period last year. Pfizer also reported revenues of $13.63 billion, a -3% slide from its sales in Q4 last year.
Adjusted to exclude 1-time items, earnings per share were 47¢, behind consensus on The Street, where analysts were looking for sales of $13.55 billion.
Get the full story at our sister site, Drug Delivery Business News.
The post Pfizer misses on Q4 earnings appeared first on MassDevice.
from MassDevice http://ift.tt/2jQAJK0
Cap comentari:
Publica un comentari a l'entrada